Improving Development and Distribution of Diagnostic Tests Act

Bill 118 s 2672, also known as the Improving Development and Distribution of Diagnostic Tests Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to enhance the process of developing and distributing diagnostic tests for various diseases and health conditions.

The bill aims to streamline the approval process for diagnostic tests by providing additional funding and resources to the Food and Drug Administration (FDA) to expedite the review and approval of these tests. This will help ensure that new and innovative diagnostic tests can reach the market more quickly, allowing for earlier detection and treatment of diseases.

Additionally, the bill seeks to improve the coordination between federal agencies, such as the FDA and the Centers for Disease Control and Prevention (CDC), to better track and monitor the distribution of diagnostic tests. This will help prevent shortages and ensure that tests are distributed equitably across the country. Overall, the Improving Development and Distribution of Diagnostic Tests Act is aimed at improving public health by making it easier for healthcare providers to access and use diagnostic tests, ultimately leading to better health outcomes for patients.